Navigation Links
ViroPharma Incorporated Reports First Quarter 2009 Financial Results
Date:4/29/2009

tements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.

                            VIROPHARMA INCORPORATED
                      Selected Financial Information- GAAP

    Consolidated Statements of Operations:               Three months ended
    (in thousands, except per share data)                    March 31,
                                                             ---------
                                                             2009     2008*
                                                             ----     ----
                                                              (unaudited)
    Revenues:
    Net product sales                                     $60,190  $50,937
                                                          -------  -------
    Revenues:                                              60,190   50,937
                                                           ------   ------

    Costs and Expenses:
    Cost of sales (excluding amortization of product
     rights)                                                3,929    1,918
    Research and development                               19,798   14,968
    Selling, general and administrative                    24,264   12,846
    Intangible amortization                                 7,257    1,688
    Goodwill impairment                                    65,099        -
                                                           ------      ---
    Total costs and expenses                              120,347   31,420
                                                          -------   ------
    Operating (loss) income                               (60,157)  19,517

    Interest income                                           144    6,311
    Interest expense                                       (3,309)  (3,127)
    G
'/>"/>
SOURCE  ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 

Related biology technology :

1. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
2. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
4. ViroPharma to Present at Three November Healthcare Conferences
5. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
6. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
7. ViroPharma to Present at Three October Healthcare Conferences
8. ViroPharma to Present at Three September Healthcare Conferences
9. ViroPharma To Acquire Lev Pharmaceuticals
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 •    First of its ... for sustainability ,     New facility will help solve ... , Syngenta unveiled its new crop research ... company’s RTP Innovation Center. The first of its kind, ... simulate any agricultural climate and precisely measure plant inputs ...
(Date:5/17/2013)... Health, Inc., a company developing natural compounds to address ... is today reporting top-line results from a Phase Ib ... drug-resistant epilepsy.  The data are being presented at the ... Dr. Steven Schachter , Harvard Medical ... In this study, INS001 appeared safe and well tolerated. ...
(Date:5/17/2013)... May 17, 2013 IAC Industries wants to ... start up laboratory needing to set up and furnish a ... a larger facility within a year’s time. How does a ... the laboratory is temporary? What is efficient and cost-effective? ... workstations from IAC Industries. The planners at DisperSol determined that ...
(Date:5/16/2013)... 16, 2013 In late 2012, Dr. Sarah ... to doctors in China about Appearance Medicine . Although ... was her first trip to lecture in China, and quite ... and Fuzhou, home to 12 and 7 million people respectively. ... high at this point in time. As Dr. Hart passed ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2
... 18 Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a ... increased its direct-sales staff significantly, based on a,number of ... The,company, which had only two direct salespersons in the ... to 21 by 2009. The increase is a significant ...
... ACEL ) today announced that it has ... Protein Laboratories LLC (SPL) for the,commercial production of ... currently being evaluated as a treatment for,unresectable malignant ... "SPL has been involved in the production ...
... International Group, Ltd.,(Bloomberg: BIG SP, Company or Biosensors), ... (CE) Mark approval for its,BioMatrix(R) drug-eluting stent system, ... and the countries in Asia and Latin America,that ... system,developed internally by the Company, consists of a ...
Cached Biology Technology:Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories 2Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories 3Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 2Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 3Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System 4
(Date:5/16/2013)... 16, 2013 The relationship between the heritable ... not been clear. Schizophrenia is commonly associated with ... are clues that reduced IQ may be linked ... reduced cognitive ability may precede the onset of ... in healthy relatives of people diagnosed with schizophrenia. ...
(Date:5/16/2013)... an ancient extinct creature with ,scissor hand-like, claws in ... his favourite movie star. , The 505 million ... Koo-ten-ee-che-la depp-eye), which is a distant ancestor of lobsters ... for his starring role as Edward Scissorhands - a ... creation, who has scissors for hands. , ...
(Date:5/16/2013)... (GWA), where the entirety of an individual,s DNA is ... which can cause health problems is a massively useful ... pose major ethical problems if used incorrectly, say new ... published on line today (16 May 2013) in the ... based on whole genome and on exome* sequencing and ...
Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2Actor Johnny Depp immortalized in ancient fossil find 2European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2
... development of alternative fuel will greatly benefit the U.S., ... by the Ecological Society of America (ESA), the nation,s ... effectively reap the social and economic benefits of biofuel ... land-use choices on our ecosystems. In the report, ...
... fog has decreased significantly over the past 100 years, potentially ... to a new study by University of California, Berkeley, scientists. ... natural cycle of the result of human activity, but the ... redwood ecosystem, the scientists say. , "Since 1901, the average ...
... new study reveals that a common underlying mechanism is ... all cause complex defects in brain development and function. ... Alpha-Thalassemia mental Retardation, X-linked syndrome (ATR-X) have each been ... proteins and DNA that make up chromosomes and control ...
Cached Biology News:Beyond the corn field: Balancing fuel, food and biodiversity 2Fog has declined in past century along California's redwood coast 2Fog has declined in past century along California's redwood coast 3Fog has declined in past century along California's redwood coast 4A common thread links multiple human cognitive disorders 2
WNV Core Antibody...
Rad51, N-terminal...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products: